Nymox Pharmaceutical OverviewNymox Pharmaceutical EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NYMX.
Quarterly EBIT
-$1.10M
↑ 37.96% YoY
As of Jun 30, 2023
Annual EBIT (TTM)
-$2.29M
↑ 82.27% YoY
Trailing 12 months ending Jun 30, 2023
Nymox Pharmaceutical OverviewEBIT (Earnings Before Interest and Taxes) analysis for NYMX.
As of Jun 30, 2023
Trailing 12 months ending Jun 30, 2023